---
layout: post
title: "Immunic Announces Closing of Oversubscribed Private Placement Financing"
date: 2026-02-17T21:05:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/immunic-announces-closing-of-oversubscribed-private-placement-financing-302689923.html
significance: 7.00
---

<p>– Upfront Proceeds of USD 200 Million, with Potential for up to USD 200 Million in Additional Proceeds – – Expected to Fund Completion of Phase 3 ENSURE Trials in Relapsing Multiple Sclerosis, Initiation of Phase 3 Trial in Primary Progressive Multiple Sclerosis, and Begin of Transition...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/immunic-announces-closing-of-oversubscribed-private-placement-financing-302689923.html)

**Published:** 2026-02-17 21:05:00 +0000

**Significance Score:** 7.00

[View original](https://www.prnewswire.com/news-releases/immunic-announces-closing-of-oversubscribed-private-placement-financing-302689923.html)
